BD Vacutainer Safety-Lok Blood Collection Set; BD Vacutainer Safety-Lok Blood Collection Set with Pre-Attached Holder
Becton Dickinson and Company · Decision date Apr 10, 2026
What did the FDA decide?
FDA records K252506 as a 510(k) premarket notification, with a decision dated Apr 10, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Clinical Chemistry
- Decision date
- Apr 10, 2026
Regulatory record facts
- Identifier
- K252506
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Becton Dickinson and Company
- Product code
- JKA
- Decision code
- SESE
- Decision date
- Apr 10, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Tubes, Vials, Systems, Serum Separators, Blood Collection.
- Applicant
- Becton Dickinson and Company
- Product code
- JKA
- FDA device class
- 2
FDA decision timeline
K252506 received
Application receipt date recorded by FDA.
K252506 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code JKA
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| CMT Health PTE., Ltd. | 510(k) clearance | Oct 28, 2026 | FDA | |
| Sol-Millennium Medical, Inc. | 510(k) clearance | Oct 21, 2026 | FDA | |
| Becton Dickinson and Company | 510(k) clearance | Oct 16, 2026 | FDA | |
| CMT Health PTE., Ltd. | 510(k) clearance | Sep 25, 2026 | FDA | |
| Zhejiang Kindly Medical Device Co., Ltd. | 510(k) clearance | Jun 2, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Becton Dickinson and Company
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Franklin Lakes, NJ
Sources and methodology
- Original FDA record: K252506
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



